Evidence map›Paper›PMID 38187550›Full record

ArticlebioRxiv : the preprint server for biology2023

Zelda is dispensable for

Tommy O'Haren, Tsutomu Aoki, Leila E Rieder

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Tommy O'HarenEmory University Department of Biology, Atlanta, GA 30322, USA.
Tsutomu AokiDepartment of Molecular Biology, Princeton University, Princeton, NJ 08540 USA.
Leila E RiederEmory University Department of Biology, Atlanta, GA 30322, USA.ORCID 0000-0001-9851-0145
Emory University · USPrinceton University · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008490 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2022
$8.0M
Developmental Regulation of Nuclear DomainsR35GM142724 · NIGMS · EMORY UNIVERSITY · PI Leila Elizabeth Rieder · 2021 to 2026
$2.6M
Mechanisms of Nuclear Body Formation in the Early EmbryoR00HD092625 · NICHD · EMORY UNIVERSITY · PI RIEDER, LEILA ELIZABETH · 2019 to 2021
$640k
Developmental regulation of histone genes by pioneer factors and three-dimensional architectureF31HD108974 · NICHD · EMORY UNIVERSITY · PI O'HAREN, THOMAS E · 2023 to 2025
$146k
NICHD NIH HHS F31 HD108974NICHD NIH HHS R00 HD092625NIGMS NIH HHS R35 GM142724NIGMS NIH HHS T32 GM008490
6 · The paper itself

Abstract

To ensure that the embryo can package exponentially increasing amounts of DNA, replication-dependent histones are some of the earliest transcribed genes from the zygotic genome. However, how the histone genes are identified is not known. The pioneer factors Zelda and CLAMP collaborate at a subset of genes to regulate zygotic genome activation in Drosophila melanogaster and target early activated genes to induce transcription. CLAMP also regulates the embryonic histone genes and helps establish the histone locus body, a suite of factors that controls histone mRNA biosynthesis. The relationship between Zelda and CLAMP led us to hypothesize that Zelda helps identify histone genes for early embryonic expression. We found that Zelda targets the histone locus early during embryogenesis, prior to histone gene expression. However, depletion of

Identifiers

PMID38187550
PMCPMC10769256
OpenAlexW4390011608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.